Active, Not Recruiting
The Study of CIK Plus S-1 and Bevacizumab as Maintenance Treatment for Patients With Advanced Colorectal Cancer
NCT02487992
- Conditions
- Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +8 more
- Locations
-
Not specified